Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 561,572 | 616,214 | 730,367 | 840,440 | 944,073 |
| Receivables | 22,443 | 23,942 | 18,891 | 24,559 | 17,899 |
| TOTAL | $602,744 | $662,480 | $783,362 | $903,020 | $1,001,749 |
| Non-Current Assets | |||||
| PPE Net | 203,720 | 211,035 | 210,582 | 195,992 | 188,193 |
| Investments And Advances | 48,704 | 62,103 | 62,490 | 76,021 | 78,565 |
| Intangibles | 72,510 | 79,566 | 90,602 | 125,316 | 131,979 |
| Other Non-Current Assets | 449,771 | 465,699 | 478,219 | 281,412 | 264,856 |
| TOTAL | $774,705 | $818,403 | $841,893 | $678,741 | $663,593 |
| Total Assets | $1,377,449 | $1,480,883 | $1,625,255 | $1,581,761 | $1,665,342 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,169 | 15,700 | 140,147 | 26,995 | 9,323 |
| Accrued Expenses | 65,387 | 75,833 | N/A | 108,436 | 110,051 |
| TOTAL | $107,266 | $114,427 | $166,154 | $169,043 | $163,860 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 27,710 | 22,894 | 26,007 | 33,612 | 44,486 |
| Other Non-Current Liabilities | 455,342 | 463,266 | 473,160 | 259,381 | 246,268 |
| TOTAL | $554,125 | $568,513 | $626,029 | $425,448 | $404,330 |
| Total Liabilities | $661,391 | $682,940 | $792,183 | $594,491 | $568,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,034 | 57,479 | 55,575 | 55,282 | 53,810 |
| Common Shares | 5 | 5 | 206 | 202 | 5 |
| Retained earnings | -5,837,557 | -5,730,023 | -5,673,620 | -5,456,439 | -5,290,528 |
| Other shareholders' equity | -1,806 | 263 | -1,723 | -1,551 | 1,484 |
| TOTAL | $716,058 | $797,943 | $833,072 | $987,270 | $1,097,152 |
| Total Liabilities And Equity | $1,377,449 | $1,480,883 | $1,625,255 | $1,581,761 | $1,665,342 |